Caladrius, PCT and TrakCel to Drive Cell Therapy Manufacturing Excellence

Business News
Print
CARDIFF, Wales--(BUSINESS WIRE)--TrakCel Ltd. today announced a collaboration agreement with Caladrius Biosciences, Inc. (Nasdaq:CLBS) and its subsidiary PCT, a Caladrius Company (PCT) to implement its cell therapy process management and supply chain integration technology. TrakCel’s technology integrates and automates the entire cell therapy process end-to-end while providing real-time audit logs and chain-of-custody records to stakeholders. It further reduces the implementation risks associat

imageimage

Read more